Leerink Partnrs Forecasts Weaker Earnings for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Leerink Partnrs dropped their Q1 2025 earnings per share (EPS) estimates for Henry Schein in a research report issued to clients and investors on Wednesday, April 9th. Leerink Partnrs analyst M. Cherny now expects that the company will earn $1.12 per share for the quarter, down from their previous forecast of $1.14. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein's Q2 2025 earnings at $1.14 EPS, Q4 2025 earnings at $1.16 EPS, FY2025 earnings at $4.61 EPS and FY2028 earnings at $6.00 EPS.

A number of other research firms have also weighed in on HSIC. Barrington Research reissued an "outperform" rating and issued a $90.00 price objective on shares of Henry Schein in a research report on Wednesday, February 26th. Wells Fargo & Company assumed coverage on shares of Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price for the company. StockNews.com upgraded Henry Schein from a "hold" rating to a "buy" rating in a research report on Wednesday, April 9th. UBS Group lowered their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Finally, Jefferies Financial Group increased their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Five research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $81.10.

Henry Schein Price Performance

HSIC traded down $0.70 during trading on Friday, reaching $63.58. 378,148 shares of the company traded hands, compared to its average volume of 1,603,704. The company has a market cap of $7.90 billion, a P/E ratio of 26.16, a PEG ratio of 2.13 and a beta of 0.84. The firm has a fifty day simple moving average of $71.27 and a 200 day simple moving average of $72.13. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein has a 12-month low of $60.49 and a 12-month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to analysts' expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business's quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the business earned $0.66 earnings per share.

Hedge Funds Weigh In On Henry Schein

A number of institutional investors have recently bought and sold shares of HSIC. Simon Quick Advisors LLC acquired a new stake in Henry Schein during the first quarter worth approximately $225,000. SG Americas Securities LLC bought a new position in Henry Schein in the 1st quarter valued at approximately $21,551,000. GAMMA Investing LLC increased its holdings in Henry Schein by 37.8% in the first quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock valued at $270,000 after purchasing an additional 1,081 shares during the period. Farther Finance Advisors LLC increased its position in Henry Schein by 237.3% during the 1st quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock valued at $186,000 after purchasing an additional 1,898 shares during the period. Finally, UMB Bank n.a. boosted its position in Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after acquiring an additional 201 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Insider Buying and Selling

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares of the company's stock, valued at $1,762,147.20. This trade represents a 9.50 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.14% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.